The long-term efficacy of hepatitis B vaccine, long-term effectiveness of hepatitis B immunisation programmes, immune memory induced by hepatitis B vaccine, current booster policies, and impact of hepatitis B virus mutants on immunisation programmes were reviewed at the Viral Hepatitis Prevention Board (VHPB) meeting in Sevilla, Spain, March 2004. The main focus was on universal vaccination programmes with data being presented from Italy, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, The Gambia, and USA (Alaska).
Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants / D. Fitzsimons, G. Francois, A. Hall, B. McMahon, A. Meheus, A. Zanetti, B. Duval, W. Jilg, W.O. Bocher, S.N. Lu, U. Akarca, D. Lavanchy, S. Goldstein, J. Banatvala, P.V. Van Damme. - In: VACCINE. - ISSN 0264-410X. - 23:32(2005), pp. 4158-4166.
Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants
A. Zanetti;
2005
Abstract
The long-term efficacy of hepatitis B vaccine, long-term effectiveness of hepatitis B immunisation programmes, immune memory induced by hepatitis B vaccine, current booster policies, and impact of hepatitis B virus mutants on immunisation programmes were reviewed at the Viral Hepatitis Prevention Board (VHPB) meeting in Sevilla, Spain, March 2004. The main focus was on universal vaccination programmes with data being presented from Italy, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, The Gambia, and USA (Alaska).
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
